share_log

AbbVie | 25-NSE: Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities (and amendment thereto)

SEC ·  Jun 3, 2024 23:31

Summary by Futu AI

The New York Stock Exchange (NYSE) has notified the Securities and Exchange Commission (SEC) of its intention to delist the entire class of securities of Biora Therapeutics, Inc. This action is set to take place at the start of business on June 14, 2024, in accordance with Rule 12d2-2(a). The securities in question were fully redeemed, paid at maturity, or retired on June 3, 2024, which led to their suspension from trading on the same day. The notice of effectiveness for this action was filed with the SEC and is set to become effective on May 31, 2024, at 4:00 P.M.
The New York Stock Exchange (NYSE) has notified the Securities and Exchange Commission (SEC) of its intention to delist the entire class of securities of Biora Therapeutics, Inc. This action is set to take place at the start of business on June 14, 2024, in accordance with Rule 12d2-2(a). The securities in question were fully redeemed, paid at maturity, or retired on June 3, 2024, which led to their suspension from trading on the same day. The notice of effectiveness for this action was filed with the SEC and is set to become effective on May 31, 2024, at 4:00 P.M.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Doc 2

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Heat List
    US
    SymbolLatest Price% Chg

    No Data

    Hot News
    Updated